Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

That wraps up our initial coverage of Rocket Lab’s Q2 results. Thank you for stopping by!

Rocket Lab reported further progress across the assembly, integration, and testing of Neutron’s first-flight hardware.

Most importantly, production of the reusable rocket’s Stage 1 tank remains aligned with Rocket Lab’s target of delivering Neutron to the launch pad in Q4 2026.

The company also secured a $397 million U.S. Space Force contract to deliver multiple Flatellite spacecraft that will launch aboard Neutron.

Rocket Lab is one of only two vendors selected to provide both the spacecraft and launch services for the program, offering a major validation of the company’s vertically integrated strategy as Neutron approaches its inaugural mission.

Rocket Lab expects its record-setting growth to continue in Q3, guiding for revenue between $250-$265 million.

The midpoint would represent about 10% sequential growth from the record $234.1 million generated during Q2.

However, Rocket Lab expects a non-GAAP gross margin between 35% and 37%, down from 41.5% in Q2, and an adjusted EBITDA loss between $17-$23 million.

Investors will now be watching whether the company can sustain its revenue momentum while limiting the anticipated margin compression.

Rocket Lab exited the second quarter with a record $2.36 billion backlog, representing a 137% increase from the prior-year period.

The company also secured more than $437 million in new launch contracts across Electron, HASTE, and Neutron during Q2 and the weeks following the quarter.

Rocket Lab’s launch backlog now includes more than 90 missions, while new contracts signed across its launch and Space Systems businesses since the end of Q2 have already surpassed $1 billion.

The growing backlog provides Rocket Lab with greater revenue visibility as it expands across commercial and national-security space markets.

Rocket Lab just reported earnings, with shares initially down 5% following the report. Here are the key numbers:

• Revenue: $234.1 million vs. $230.9 million expected
• EPS: ($0.08) vs. ($0.08) expected

Quick Read:

Revenue beat expectations by roughly 1%, while Rocket Lab’s loss per share came in line with estimates.
Revenue soared 62% year over year and 17% sequentially, although the modest headline beat failed to satisfy investors as shares fell 5%.

This live blog is being updated by Thomas Richmond, a 24/7 Wall St. contributor. Simply stay on this page, and new updates will appear below automatically.

We expect Rocket Lab to release Q2 earnings shortly after 4:05 p.m. ET.

Rocket Lab is down 3.6% today, and the intraday tape shows a 6.90-point range (roughly 8.5%) today, pointing to elevated implied volatility priced into tonight’s report.

Aggregated across the three nearest expirations, call volume of 140,747 outpaces put volume of 65,893, a 2.14x ratio, confirming a bullish tilt.

Structural positioning is even more one-sided. January 2027 shows 136,227 call open interest, with January 2028 close behind at 129,425. September 18 calls trade at a 3.03x ratio.

Translation: Dealers expect a large move, traders are leaning long into it, and IV crush post-report will punish premium buyers unless Rocket Lab clears management’s $225M-$240M revenue guide.

With the earnings report due after the close, here are some of analysts top expected questions ahead of tonight’s call.

Top 5 Analyst Questions

• Is Neutron’s Q4 2026 debut still firm after the Archimedes qualification work?
• How does the $325M Geost deal contribute to Space Systems margins?
• What is the revenue ramp path from the $816M SDA Tranche 3 award?
• Timeline for Mynaric and Motiv integration synergies?
• When does adjusted EBITDA turn positive given $20M-$26M guided loss?

Red Flags to Watch

• Any Neutron slip beyond 2026.
• Fresh ATM issuance after the $450M Q1 raise.
• Gross margin below the 38% floor.
• Operating cash flow worse than Q1’s -$50.3M.

The Setup: Consensus vs. Guidance

Rocket Lab (NASDAQ:RKLB) rallied 27.53% in the past week to $80.44. Revenue above $240 million plus a firm Neutron timeline could reignite the run; any slippage risks a repeat of Q1’s +34.22% move in reverse.

Wall Street consensus lands at $230.94 million in revenue and an EPS loss of -0.0767, comfortably inside management’s guide. Beyond the headline, keep an eye on backlog expansion past the $2.20 billion Q1 mark and new Neutron contract signings.

Options desks are leaning bullish, with the Aug 14 call/put volume ratio at 2.01x and Aug 28 at 4.72x. Prediction markets price 67% odds of a beat, yet 93.5% odds the stock closes down today, a classic sell-the-news setup.

Technical Setup Into the Close

Rocket Lab enters tonight’s report at $80.44, sitting below its 50-day SMA of 90.55 after a violent round-trip. Shares slid to $64.95 on July 31 before ripping 27.53% over the next week. RSI has recovered from a deeply oversold 29.95 on July 29 to 56.24, leaving room before overbought.

Key resistance sits at the post-Q1 high of $105.47, the all-time zone. Support anchors near $72-76. Options positioning skews bullish: the August 14 expiration shows a 2.01x call/put volume ratio, and January 2027 calls dominate at 6.37x. Strike-level IV was unavailable, but Polymarket assigns $88 a 69.5% probability for August, framing the expected upside band.

Bull Case

• Record $2.2 billion backlog and selection alongside Raytheon for the Space-Based Interceptor program under Golden Dome anchor a multi-year defense tailwind.
• Q1 revenue jumped 63.5% YoY with non-GAAP gross margin at 43%, showing operating leverage.
• Neutron remains on “aggressive schedule towards the first launch later this year”, a potential major catalyst.
• Analyst consensus target sits at $111.31, with 14 Buy ratings.

Bear Case

• Q1 net loss of $45 million continues, alongside a $450 million ATM raise that dilutes holders.
• Neutron slippage risk remains after a prior stage-1 tank test failure.
• Polymarket assigns 93.5% odds of RKLB closing down today, signaling sell-the-news risk.
• Insiders logged 86 recent transactions net skewed to selling.

Rocket Lab reports second-quarter earnings after the market closes today, with management guiding for revenue between $225 million and $240 million.

Investors will be listening closely for confirmation that Neutron remains on schedule for its highly anticipated late-2026 debut following last year’s stage-1 tank testing setback.

Margins will also be something management pays close attention to, as Rocket Lab delivered a 43.0% non-GAAP gross margin in Q1, while its Q2 outlook calls for that figure to moderate to between 38-40%.

With Rocket Lab valued at roughly $50 billion despite remaining unprofitable, tonight’s report must reinforce the pillars supporting its valuation: Neutron’s development remains on track, defense contract wins continue compounding, and Space Systems margins have room to expand.

Analysts have an average price target of $111.31, implying the stock has over 30% upside today.